← Back to feed
Nairametrics·September 9, 2026 at 12:53 PM

Nigeria's counterfeit medicine crisis stems from longstanding weaknesses in the country's pharmaceutical regulatory system, according to Professor Mojisola Adeyeye, Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC). Adeyeye attributed the prevalence of fake and substandard drugs in Nigeria to regulatory gaps that have persisted over time, highlighting the need for stronger oversight of the pharmaceutical sector, Nairametrics reported.

AI summary. Verify with the original source.

NAFDACcounterfeit medicineNigeriapharmaceutical regulationMojisola Adeyeye

Read full story at Nairametrics

Listen

Audio summaries is a Premium feature

Unlock audio summaries, audio summaries, AI chat, Wikipedia facts, and ad-free reading.

$3.99 / month · cancel anytime

Go Premium

Background facts

Wikipedia facts is a Premium feature

Unlock wikipedia facts, audio summaries, AI chat, Wikipedia facts, and ad-free reading.

$3.99 / month · cancel anytime

Go Premium

Similar stories